Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Editas Medicine, Inc. Director's Dealing 2016

Feb 3, 2016

33260_dirs_2016-02-02_27ce8ec4-3cd6-406b-adb7-7d6df751e55e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Editas Medicine, Inc. (EDIT)
CIK: 0001650664
Period of Report: 2016-02-02

Reporting Person: Liu David R. (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 480769 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $6.48 2025-09-13 Common Stock (96153) Direct

Footnotes

F1: These shares are restricted stock owned by David Liu and issued pursuant to a restricted stock agreement between the Issuer and Mr. Liu. Twenty-five percent of the shares vested on November 21, 2013, and the remainder are scheduled to vest in equal monthly installments from August 1, 2013 until August 1, 2017.

F2: This option was granted on September 14, 2015 and is scheduled to vest over four years with the shares scheduled to vest in equal quarterly installments beginning on December 10, 2015.